We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies

19 hedge funds and large institutions have $2.33M invested in NeuroOne Medical Technologies in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,090% more capital inflows, than outflows

Capital inflows: $1.89M | Capital outflows: $16.9K

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

36% more funds holding

Funds holding: 14 → 19 (+5)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

5.6% more ownership

Funds ownership: 5.35% → 10.95% (+5.6%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
19
Holders Change
+5
Holders Change %
+35.71%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
4
Reduced
3
Closed
1
Calls
$11​K
Puts
–
Net Calls
+$11​K
Net Calls Change
+$11​K

NMTC Hedge Fund Activity: Q3 2023 in Review

19 of the 6,315 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2023, worth a combined $2.33M — up 107% from $1.13M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NMTC positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $1.4M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $12.3K sold.

  • 19 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2023, up from 14 in Q2 2023.
  • Funds reported $2.33M of NeuroOne Medical Technologies stock for Q3 2023, up 107% quarter-over-quarter.
  • 6 funds opened new NeuroOne Medical Technologies positions in Q3 2023 and 1 closed out, a net change of +5 holders.
  • The largest NeuroOne Medical Technologies buyer in Q3 2023 was Nantahala Capital Management, an estimated $1.4M added.
  • The largest NeuroOne Medical Technologies seller in Q3 2023 was Tower Research Capital (TRC), an estimated $12.3K sold.

Based on aggregated 13F filings for Q3 2023.